Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Cancer|July 3, 2024
Impact of three-dimensional-printing technology guidance on surgical outcomes for retroperitoneal sarcoma: A propensity score-matched studyJiaxin Lin, Yingru Li, Xiaochuang Feng, et al.
International Journal of Cancer|July 6, 2023
China special issue on gastrointestinal tumors-Radiological features of pathological complete response in mismatch repair deficient colorectal cancer after neoadjuvant PD-1 blockade: A post hoc analysis of the PICC phase II trialWuteng Cao, Huabin Hu, Jiao Li, et al.
Med (New York, N.Y.)|May 25, 2024
PD-1 blockade plus COX inhibitors in dMMR metastatic colorectal cancer: Clinical, genomic, and immunologic analyses from the PCOX trialZehua Wu, Yuanzhe Zhang, Yi Cheng, et al.
Nature Communications|January 21, 2026
Neoadjuvant chemoradiotherapy plus sintilimab in proficient mismatch repair locally advanced rectal cancer with intermediate/high-immunoscore (SILAR): a single-arm phase II trialXiaobin Zheng, Huashan Liu, Lishuo Shi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 22, 2026
Combined Upadacitinib and Vedolizumab as 8-Week Induction Therapy for Moderate-to-Severe Ulcerative Colitis: A Multicenter, Randomized Controlled TrialJiayin Yao, Hongzhen Wu, Luying Wu, et al.
Eclinicalmedicine|December 13, 2023
Comparative effectiveness of ustekinumab vs. vedolizumab for anti-TNF-naïve or anti-TNF-exposed Crohn's disease: a multicenter cohort studyHongsheng Yang, Zhaopeng Huang, Miao Li, et al.
Annals of Translational Medicine|March 14, 2022
mFOLFOXIRI with or without bevacizumab for conversion therapy of RAS/BRAF/PIK3CA mutant unresectable colorectal liver metastases: the FORBES non-randomized phase II trialCailu Shen, Huabin Hu, Yue Cai, et al.
Chinese Medical Journal|December 3, 2025
Stool-based methylated syndecan-2 test and fecal immunochemical test for advanced colorectal neoplasia screening in the Chinese population: A multicenter randomized noncomparative studyYufeng Chen, Jiaxin Li, Kai Gu, et al.
Cancer Medicine|June 18, 2024
PD-1 blockade enhances the effect of targeted chemotherapy on locally advanced pMMR/MSS colorectal cancerFengyun Pei, Wan He, Yinghua Duan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2024
Neoadjuvant Modified Infusional Fluorouracil, Leucovorin, and Oxaliplatin With or Without Radiation Versus Fluorouracil Plus Radiation for Locally Advanced Rectal Cancer: Updated Results of the FOWARC Study After a Median Follow-Up of 10 YearsJianwei Zhang, Pan Chi, Lishuo Shi, et al.
Pageof 5